Development of Paclitaxel Proliposomal Dry Powder Inhaler (PTX-PLM-DPI) by Freeze-Drying Method for Lung Cancer
Despite various efforts, a successful selective delivery system for chemotherapeutic agents for lung cancer is still lacking. Dry powder inhaler (DPI) systems based on proliposomes (PLMs) could be a potential system for the efficient delivery of paclitaxel to lungs. PLM-based DPI prepared with a fre...
Main Authors: | Chinmoyee Borah, Trideep Saikia, Alakesh Bharali, Madhuchandra Lahan, Nikhil Biswas, Bhanu P Sahu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Drugs and Drug Candidates |
Subjects: | |
Online Access: | https://www.mdpi.com/2813-2998/3/1/16 |
Similar Items
-
Levofloxacin-Proliposomes: Opportunities for Use in Lung Tuberculosis
by: Teerapol Srichana, et al.
Published: (2012-08-01) -
Proliposomes: an approach for the development of stable liposome
by: Namita Singh, et al.
Published: (2020-03-01) -
Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing
by: Priyanka Kunamaneni, et al.
Published: (2022-07-01) -
Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment
by: Wing-Hin Lee, et al.
Published: (2020-12-01) -
Long-Circulating and Fusogenic Liposomes Loaded with Paclitaxel and Doxorubicin: Effect of Excipient, Freezing, and Freeze-Drying on Quality Attributes
by: Marjorie Roque, et al.
Published: (2022-12-01)